Efficacy and Safety of Immunotherapy with Interferon-Gamma in the Management of Chronic Sulfur Mustard-Induced Cutaneous Complications: Comparison with Topical Betamethasone 1%

Table 2

Bivariate analyses in the IFN-γ group.

		IL-4		IL- 6		IgE
		r	𝑃 value	r	𝑃 value	r	𝑃 value
DLQI	Pretrial	−0.48	0.04	0.61	0.01	−0.27	0.28
	Post-trial	−0.06	0.81	−0.54	0.02	0.02	0.92
SCORAD-A	Pretrial	−0.18	0.48	0.47	0.05	−0.03	0.9
	Post-trial	−0.24	0.34	0.13	0.61	−0.29	0.24
SCORAD-B	Pretrial	0.88	0.001	−0.56	0.01	0.32	0.2
	Post-trial	−0.06	0.81	0.24	0.35	−0.22	0.39
SCORAD-C	Pretrial	0.74	0.01	−0.23	0.35	0.13	0.61
	Post-trial	−0.12	0.63	0.04	0.87	−0.14	0.57

DLQI: dermatology life quality index; SCORAD: scoring atopic dermatitis. SCORAD-A, -B, and -C denote extent, intensity, and subjective symptoms of the disorder, respectively.